05:06 AM EDT, 09/23/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) said Monday that it priced its previously announced public offering of about 12.7 million common shares at $5.50 a share, for total proceeds of approximately $70 million.

The company said it granted the underwriters a 30-day option to purchase up to 1.9 million additional common shares at the same offering price.

The offering is expected to close on Wednesday and Eupraxia said proceeds will be used to advance its product pipeline, for the research and development of additional pipeline candidates, and general corporate purposes.